Hypogammaglobulinemia, infections and COVID-19 in people with multiple sclerosis treated with ocrelizumab
Mario Habek, Dominik Piskač, Tereza Gabelić, Barbara Barun, Ivan Adamec, Magdalena Krbot Skorić
Topics & Concepts
OcrelizumabMedicineMultiple sclerosisInternal medicineHypogammaglobulinemiaImmunologyAntibodyRituximabLymphomaMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersImmunodeficiency and Autoimmune Disorders